Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Photo: Liz O. Baylen/Getty Images
Cleveland County District Judge Thad Balkman decided on Friday that Purdue Pharma — the infamous manufacturer of OxyContin — along with Johnson & Johnson and Teva Pharmaceuticals Industries Ltd., are due in court May 28 in a multibillion-dollar lawsuit, despite efforts to postpone the trial, reports Reuters.
Details: Oklahoma's Attorney General Mike Hunter has accused the companies of feeding the state's opioid epidemic. Reuters also reported that Purdue was considering filing for bankruptcy, alleging such action could give the company time to review legal liabilities and delay the court case. Purdue's attorney argued moving the trial to Sept. 16 was necessary because the state "belatedly turned over 1.6 million pages of records critical to Purdue's defense ... But the judge said the drugmakers had not established the state's actions had prejudiced them."
Go deeper: Purdue Pharma let doctors underestimate OxyContin's strength